Jinyu Historical Income Statement

600201 Stock

7.05 0.04 0.57%

Historical analysis of Jinyu Bio income statement accounts such as Selling General Administrative of 230.1 M, Total Revenue of 1 B or Operating Income of 316.5 M can show how well Jinyu Bio Technology Co performed in making a profits. Evaluating Jinyu Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Jinyu Bio's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Jinyu Bio Technology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Jinyu Bio Technology is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinyu Bio Technology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Jinyu Income Statement Analysis

Jinyu Bio Technology Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Jinyu Bio shareholders. The income statement also shows Jinyu investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Jinyu Bio Income Statement Chart

At present, Jinyu Bio's Net Income Applicable To Common Shares is projected to increase significantly based on the last few years of reporting. The current year's Net Income From Continuing Ops is expected to grow to about 378.1 M, whereas Interest Expense is forecasted to decline to about 50.7 K.

Selling General Administrative Total Revenue Operating Income Cost Of Revenue

Total Revenue

Total revenue comprises all receipts Jinyu Bio Technology generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Operating Income

Operating Income is the amount of profit realized from Jinyu Bio Technology operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Jinyu Bio Technology Co is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Jinyu Bio Technology income statement and represents the costs associated with goods and services Jinyu Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Jinyu Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Jinyu Bio Technology current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinyu Bio Technology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Operating Income	426.3M	297.7M	324.8M	316.5M
Total Revenue	1.8B	1.5B	1.6B	1.0B

Operating Income Total Revenue

Jinyu Bio income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.83	0.56	0.67	0.54	0.55	0.43	0.12	0.64	0.23	0.5	-0.04	-0.11	0.54	0.5	-0.37	0.43	0.43	-0.33	0.46
Total Revenue	0.83		0.78	0.81	0.75	0.77	0.62	0.3	0.74	0.56	0.69	0.23	0.1	0.68	0.72	-0.32	0.62	0.62	-0.36	0.48
Operating Income	0.56	0.78		0.28	0.99	1.0	0.95	0.17	0.2	0.83	0.16	0.73	0.66	0.13	0.22	0.3	0.19	0.17	0.23	-0.14
Cost Of Revenue	0.67	0.81	0.28		0.24	0.27	0.09	0.36	0.97	0.11	0.93	-0.3	-0.43	0.93	0.93	-0.75	0.79	0.82	-0.76	0.88
Income Before Tax	0.54	0.75	0.99	0.24		1.0	0.95	0.17	0.16	0.84	0.12	0.76	0.69	0.09	0.17	0.34	0.15	0.12	0.27	-0.18
Net Income	0.55	0.77	1.0	0.27	1.0		0.94	0.17	0.2	0.85	0.16	0.75	0.67	0.13	0.2	0.31	0.18	0.15	0.25	-0.15
Income Tax Expense	0.43	0.62	0.95	0.09	0.95	0.94		0.04	0.0	0.76	-0.04	0.75	0.72	-0.07	0.0	0.48	0.07	0.04	0.38	-0.31
Minority Interest	0.12	0.3	0.17	0.36	0.17	0.17	0.04		0.31	-0.02	0.36	-0.05	-0.18	0.22	0.54	-0.32	-0.06	0.03	-0.35	0.22
Research Development	0.64	0.74	0.2	0.97	0.16	0.2	0.0	0.31		0.05	0.96	-0.34	-0.47	0.96	0.9	-0.8	0.8	0.81	-0.79	0.91
Gross Profit	0.23	0.56	0.83	0.11	0.84	0.85	0.76	-0.02	0.05		0.08	0.9	0.82	0.08	0.07	0.48	0.2	0.12	0.45	-0.24
Other Operating Expenses	0.5	0.69	0.16	0.93	0.12	0.16	-0.04	0.36	0.96	0.08		-0.31	-0.45	0.98	0.93	-0.77	0.84	0.85	-0.79	0.91
Net Income From Continuing Ops	-0.04	0.23	0.73	-0.3	0.76	0.75	0.75	-0.05	-0.34	0.9	-0.31		0.97	-0.33	-0.3	0.77	-0.2	-0.27	0.73	-0.6
Ebit	-0.11	0.1	0.66	-0.43	0.69	0.67	0.72	-0.18	-0.47	0.82	-0.45	0.97		-0.45	-0.46	0.85	-0.31	-0.38	0.82	-0.69
Total Operating Expenses	0.54	0.68	0.13	0.93	0.09	0.13	-0.07	0.22	0.96	0.08	0.98	-0.33	-0.45		0.89	-0.78	0.87	0.88	-0.79	0.94
Total Other Income Expense Net	0.5	0.72	0.22	0.93	0.17	0.2	0.0	0.54	0.9	0.07	0.93	-0.3	-0.46	0.89		-0.77	0.77	0.82	-0.83	0.82
Tax Provision	-0.37	-0.32	0.3	-0.75	0.34	0.31	0.48	-0.32	-0.8	0.48	-0.77	0.77	0.85	-0.78	-0.77		-0.55	-0.62	0.96	-0.89
Net Interest Income	0.43	0.62	0.19	0.79	0.15	0.18	0.07	-0.06	0.8	0.2	0.84	-0.2	-0.31	0.87	0.77	-0.55		0.99	-0.64	0.77
Interest Income	0.43	0.62	0.17	0.82	0.12	0.15	0.04	0.03	0.81	0.12	0.85	-0.27	-0.38	0.88	0.82	-0.62	0.99		-0.73	0.79
Ebitda	-0.33	-0.36	0.23	-0.76	0.27	0.25	0.38	-0.35	-0.79	0.45	-0.79	0.73	0.82	-0.79	-0.83	0.96	-0.64	-0.73		-0.88
Reconciled Depreciation	0.46	0.48	-0.14	0.88	-0.18	-0.15	-0.31	0.22	0.91	-0.24	0.91	-0.6	-0.69	0.94	0.82	-0.89	0.77	0.79	-0.88

Click cells to compare fundamentals

Jinyu Bio Account Relationship Matchups

Jinyu Bio income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	9.2M	974.7K	42.6K	4.8M	53.4K	50.7K
Selling General Administrative	250.6M	312.5M	409.7M	339.9M	291.7M	230.1M
Total Revenue	1.1B	1.6B	1.8B	1.5B	1.6B	1.0B
Operating Income	291.8M	439.9M	426.3M	297.7M	324.8M	316.5M
Cost Of Revenue	424.6M	607.5M	677.1M	685.3M	652.2M	378.1M
Income Before Tax	253.5M	476.2M	413.3M	245.6M	315.8M	312.9M
Net Income Applicable To Common Shares	221.0M	406.2M	382.3M	210.7M	242.3M	261.6M
Net Income	221.0M	406.2M	382.3M	210.7M	283.6M	263.7M
Income Tax Expense	26.6M	53.8M	24.3M	45.4M	52.3M	49.2M
Minority Interest	221.8M	281.3M	(6.7M)	10.5M	6.5M	6.2M
Research Development	86.7M	130.8M	165.9M	133.8M	143.5M	110.1M
Gross Profit	702.2M	974.4M	1.1B	843.4M	946.0M	850.7M
Other Operating Expenses	18.5M	23.2M	24.5M	22.3M	25.6M	21.8M
Net Income From Continuing Ops	226.9M	422.4M	389.0M	200.1M	277.1M	378.1M
Ebit	211.7M	407.0M	394.2M	252.0M	226.8M	442.5M
Total Operating Expenses	853.3M	1.1B	1.3B	1.2B	1.3B	1.1B
Tax Provision	26.6M	53.8M	24.3M	45.4M	38.7M	62.3M
Net Interest Income	17.8M	19.8M	40.5M	46.0M	56.2M	36.6M
Interest Income	27.5M	21.1M	41.2M	50.9M	56.5M	39.6M
Ebitda	369.8M	650.8M	604.9M	450.6M	405.5M	553.7M
Reconciled Depreciation	107.1M	173.6M	191.6M	200.2M	189.3M	160.4M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Jinyu Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jinyu Historical Income Statement

About Jinyu Income Statement Analysis

Jinyu Bio Income Statement Chart

Total Revenue

Operating Income

Cost Of Revenue

Jinyu Bio income statement Correlations

Jinyu Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Jinyu Bio income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Jinyu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 1.0	Operating Income
Net Income	+ 1.0	Income Before Tax
Income Before Tax	+ 0.99	Operating Income
Interest Income	+ 0.99	Net Interest Income
Total Operating Expenses	+ 0.98	Other Operating Expenses
Research Development	+ 0.97	Cost Of Revenue

Reconciled Depreciation	- 0.89	Tax Provision
Reconciled Depreciation	- 0.88	Ebitda
Ebitda	- 0.83	Total Other Income Expense Net
Tax Provision	- 0.8	Research Development
Ebitda	- 0.79	Total Operating Expenses
Ebitda	- 0.79	Other Operating Expenses